Company intelligence / Profile preview

Binah.ai

Boston, Massachusetts, USAbinah.ai ↗

Ownership: Private
Employees: ~75
Development stage: Commercial

Overview

Binah.ai is not a therapeutics company; it does not conduct clinical trials in the traditional sense. Its technology has been validated through industry adoption and awards but no published clinical trial results as would be expected from pharma/biotech firms.

Therapeutic areas: Other
Modalities: Device (software-based biomarker/vital sign monitoring via camera-equipped devices)Non-pharmacological therapy (wellness/monitoring tool)
Industry: Physiological Monitoring

Partnerships

Momentum South AfricaZurich LiveWellTogether by ReneeGenerali GermanyElite Global Doctors

Beyond the preview

Go deeper on Binah.ai.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Binah.ai.

Explore the full profile